Skip to main content

Prospective, Multicenter, Open-Label, Single Arm, Phase 2 Study to Evaluate the Safety and Efficacy of Defibrotide in the Prevention of Chimeric Antigen Receptor-T-cell-associated Neurotoxicity in Subjects with Relapsed or Refractory Diffuse Large B-

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

Jazz Pharmaceuticals

Start Date

October 17, 2019

End Date

March 16, 2021
 

Administered By

Duke Cancer Institute

Awarded By

Jazz Pharmaceuticals

Start Date

October 17, 2019

End Date

March 16, 2021